Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Homji, Natasha F ^a   Mao, Xin ^a   Langsdorf, Erik F ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Chemokines; Cytokines; Endotoxin tolerance; HIV 1 transgenic rat

Indexed keywords

CCL9 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; ENDOTOXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPLEEN; TISSUE LEVEL; TRANSGENIC RAT; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; ENZYMOLOGY; FISCHER 344 RAT; GENETICS; METABOLISM;

ANALYSIS OF VARIANCE; ANIMALS; CHEMOKINES; CYTOKINES; ENDOTOXINS; HIV-1; POLYSACCHARIDES; RATS; RATS, INBRED F344; RATS, TRANSGENIC; SPLEEN;

EID: 84855283925     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-3     Document Type: Article

References (65)

1. Schletter J, Heine H, Ulmer AJ, Rietschel ET. Molecular mechanisms of endotoxin activity. Arch Microbiol 1995, 164:383-389. 10.1007/BF02529735, 8588739.
2. Cybulsky AV, Papillon J, McTavish AJ. Complement activates phospholipases and protein kinases in glomerular epithelial cells. Kidney Int 1998, 54:360-372. 10.1046/j.1523-1755.1998.00013.x, 9690202.
3. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 2003, 100:171-194. 10.1016/j.pharmthera.2003.08.003, 14609719.
4. Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol 2000, 164:5894-5904.
5. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999, 79:1-71.
6. Szabo G. [Results of recent research on opthalmic disease of tuberculous origin]. Szemeszet 1951, 88:22-28.
7. del Fresno C, Garcia-Rio F, Gomez-Pina V, Soares-Schanoski A, Fernandez-Ruiz I, Jurado T, Kajiji T, Shu C, Marin E, Gutierrez del Arroyo A, et al. Potent Phagocytic Activity with Impaired Antigen Presentation Identifying Lipopolysaccharide-Tolerant Human Monocytes: Demonstration in Isolated Monocytes from Cystic Fibrosis Patients. The Journal of Immunology 2009, 182:6494-6507. 10.4049/jimmunol.0803350, 19414804.
8. Foster S, Medzhitov R. Gene-specific control of the TLR-induced inflammatory response. Clinical Immunology 2009, 130:7-15. 10.1016/j.clim.2008.08.015, 3252731, 18964303.
9. Biswas SK, Tergaonkar V. Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance?. The International Journal of Biochemistry & Cell Biology 2007, 39:1582-1592. 10.1016/j.biocel.2007.04.021, 20833257.
10. Vigorito M, LaShomb AL, Chang SL. Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2007, 2:319-328. 10.1007/s11481-007-9078-y, 18040850.
11. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002, 4:903-914. 10.1016/S1286-4579(02)01613-1, 12106783.
12. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004, 10:71-84.
13. Cavaillon J-M, Adib-Conquy M. Critical Care 2006, 10:233. 10.1186/cc5055, 1751079, 17044947.
14. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 2007, 179:4083-4092.
15. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007,
16. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 2003, 170:508-519.
17. Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000, 164:5564-5574.
18. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance?. J Endotoxin Res 2003, 9:101-107.
19. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78. 2078557, 18026569.
20. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996, 384:529-534. 10.1038/384529a0, 8955267.
21. Giuseppe Pantaleo CG, Anthony FS. The Immunopathogenesis of Human Immunodeficiency Virus Infection. N Engl J Med 1993, 328:327-335. 10.1056/NEJM199302043280508, 8093551.
22. Cicala C, Arthos J, Selig SM, Dennis G, Hosack DA, Van Ryk D, Spangler ML, Steenbeke TD, Khazanie P, Gupta N, et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci USA 2002, 99:9380-9385. 10.1073/pnas.142287999, 123149, 12089333.
23. Clapham PR, McKnight A. HIV-1 receptors and cell tropism. Br Med Bull 2001, 58:43-59. 10.1093/bmb/58.1.43, 11714623.
24. Jiang J, Aiken C. Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 2006, 346:460-468. 10.1016/j.virol.2005.11.008, 16375941.
25. Torensma R, Figdor CG. The Achilles' heel of HIV. Med Hypotheses 2002, 58:386-387. 10.1054/mehy.2001.1541, 12056874.
26. Verani A, Gras G, Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol Immunol 2005, 42:195-212. 10.1016/j.molimm.2004.06.020, 15488608.
27. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860. 10.1056/NEJM199803263381301, 9516219.
28. Jones LE, Perelson AS. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull Math Biol 2005, 67:1227-1251. 10.1016/j.bulm.2005.01.006, 16023709.
29. Vigano A, Trabattoni D, Schneider L, Ottaviani F, Aliffi A, Longhi E, Rusconi S, Clerici M. Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr 2006, 148:389-391. 10.1016/j.jpeds.2005.11.037, 16615974.
30. Yim HCLJ, Lau JS, Lau AS. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection. AIDS 2009, 23:1473-1484. 10.1097/QAD.0b013e32832d7abe, 19622906.
31. Mirani MEI, Volpi S, Hiroi N, Chrousos GP, Kino T. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 2002, 169(11):6361-6368.
32. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 2001, 98:9271-9276. 10.1073/pnas.161290298, 55410, 11481487.
33. Chang SL, Ocasio F, Beltran J. Immunodeficient parameters in the HIV-1 transgenic rat model. Am J Infect Diseases 2007, 3:6.
34. Chang SL, Michael V. Role of HIV-1 infection in addictive behavior: A study of an HIV-1 transgenic rat model. Am J Infect Diseases 2006, 2:9.
35. Joshi PC, Raynor R, Fan X, Guidot DM. HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am J Respir Cell Mol Biol 2008, 39:218-226. 10.1165/rcmb.2007-0344OC, 2542456, 18314538.
36. Chang SL, Beltran JA, Swarup S. Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 2007, 81:8406-8411. 10.1128/JVI.00155-07, 1951376, 17553897.
37. Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 2010, 218:94-101. 10.1016/j.jneuroim.2009.09.014, 19913921.
38. Lund AK, Lucero J, Herbert L, Liu Y, Naik JS. Human immunodeficiency virus- transgenic rats exhibit pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2011,
39. Basselin M, Ramadan E, Igarashi M, Chang L, Chen M, Kraft AD, Harry GJ, Rapoport SI. Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J Cereb Blood Flow Metab 2011, 31:486-493. 10.1038/jcbfm.2010.111, 2992106,2992106, 20664612.
40. Lester R, Yao X, Ball T, McKinnon L, WR O, Kaul R, Wachihi C, Jaoko W, Rosenthal K, Plummer F. HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers. PLoS ONE 2009, 4.
41. Lester R, Yao X, Ball T, McKinnon L, Kaul R. Toll-like-receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008, 22:685-694. 10.1097/QAD.0b013e3282f4de35, 18356597.
42. Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, Lehmann V. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J 1995, 14:546-554. 398112, 7859743.
43. Ansari AW, Heiken H, Moenkemeyer M, Schmidt RE. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis. Immunol Lett 2007, 110:1-5. 10.1016/j.imlet.2007.02.012, 17434211.
44. Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
45. Levy JA. HIV and the pathogenesis of AIDS 1998, Washington, D.C.: ASM Press, 2.
46. Chen R, Zhou H, Beltran J, Malellari L, Chang S. Differential expression of cytokines in the brain and serum during endotoxin tolerance. Journal of Neuroimmunology 2005, 163:53-72. 10.1016/j.jneuroim.2005.02.012, 15885308.
47. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996, 14:457-460.
48. DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997, 278:680-686. 10.1126/science.278.5338.680, 9381177.
49. Linde T, Sandhagen B, Backman U, Fellstrom B. Altered flow properties of blood and increased plasma fibrinogen in cyclosporin-treated renal allograft recipients. Nephrol Dial Transplant 1999, 14:1525-1529. 10.1093/ndt/14.6.1525, 10383019.
50. Montgomery CP, Daum RS. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin?. Infect Immun 2009, 77:2159-2167. 10.1128/IAI.00021-09, 2681736, 19237525.
51. Sudarsanam P, Iyer VR, Brown PO, Winston F. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2000, 97:3364-3369. 10.1073/pnas.050407197, 16245, 10725359.
52. Wellmann A, Thieblemont C, Pittaluga S, Sakai A, Jaffe ES, Siebert P, Raffeld M. Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood 2000, 96:398-404.
53. Draisma A, Pickkers P, Bouw MP, van der Hoeven JG. Development of endotoxin tolerance in humans in vivo. Crit Care Med 2009, 37:1261-1267. 10.1097/CCM.0b013e31819c3c67, 19242351.
54. Mages J, Dietrich H, Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 2007, 212:723-737.
55. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009, 30:475-487. 10.1016/j.it.2009.07.009, 19781994.
56. Boasso A, Shearer GM, Chougnet C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?. J Intern Med 2009, 265:78-96. 10.1111/j.1365-2796.2008.02043.x, 2903738, 19093962.
57. Capobianchi MR. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J Biol Regul Homeost Agents 1996, 10:83-91.
58. Herbeuval JP, Shearer GM. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?. AIDS Rev 2006, 8:3-8.
59. Schols D, De Clercq E. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996, 70:4953-4960. 190447, 8764000.
60. Wilson SE, Habeshaw JA, Addawe MA, Hounsell EF, Oxford JS. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens. AIDS Res Hum Retroviruses 1997, 13:1313-1324. 10.1089/aid.1997.13.1313, 9339848.
61. Chen J, Ivashkiv LB. IFN-gamma abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci USA 2010, 107:19438-19443. 10.1073/pnas.1007816107, 2984206, 20974955.
62. Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP. Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 2002, 169:3589-3599.
63. Martin-Garcia J, Kolson DL, Gonzalez-Scarano F. Chemokine receptors in the brain: their role in HIV infection and pathogenesis. AIDS 2002, 16:1709-1730. 10.1097/00002030-200209060-00003, 12218382.
64. Bachis A, Cruz MI, Mocchetti I. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur J Neurosci 2010, 32:570-578. 10.1111/j.1460-9568.2010.07325.x, 2924467, 20670282.
65. Starr-Spires LD, Collman RG. HIV-1 entry and entry inhibitors as therapeutic agents. Clin Lab Med 2002, 22:681-701. 10.1016/S0272-2712(02)00011-2, 12244592.